Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB

Por um escritor misterioso
Last updated 20 setembro 2024
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
Metabolite Toxicity as a Driver of Aging and Disease
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
Mitochondrial-derived compartments facilitate cellular adaptation to amino acid stress - ScienceDirect
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue - Pérez - 2016 - The Journal of Physiology - Wiley Online Library
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
Research Overview — THE HUGHES LAB
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models - ScienceDirect
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
Toxicity of Tetrabromobisphenol A and Its Derivative in the Mouse Liver Following Oral Exposure at Environmentally Relevant Levels
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
Frontiers The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
IJMS, Free Full-Text
Metabolite Toxicity as a Driver of Aging and Disease — THE HUGHES LAB
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed

© 2014-2024 citytv24.com. All rights reserved.